JP2020530857A5 - - Google Patents

Download PDF

Info

Publication number
JP2020530857A5
JP2020530857A5 JP2020509441A JP2020509441A JP2020530857A5 JP 2020530857 A5 JP2020530857 A5 JP 2020530857A5 JP 2020509441 A JP2020509441 A JP 2020509441A JP 2020509441 A JP2020509441 A JP 2020509441A JP 2020530857 A5 JP2020530857 A5 JP 2020530857A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
cbd
effective amount
symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020509441A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020530857A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2018/056090 external-priority patent/WO2019034985A1/en
Publication of JP2020530857A publication Critical patent/JP2020530857A/ja
Publication of JP2020530857A5 publication Critical patent/JP2020530857A5/ja
Priority to JP2023087510A priority Critical patent/JP7590803B2/ja
Priority to JP2024197147A priority patent/JP2025024068A/ja
Pending legal-status Critical Current

Links

JP2020509441A 2017-08-14 2018-08-13 経皮カンナビジオールゲルを用いた変形性関節症の治療方法 Pending JP2020530857A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023087510A JP7590803B2 (ja) 2017-08-14 2023-05-29 経皮カンナビジオールゲルを用いた変形性関節症の治療方法
JP2024197147A JP2025024068A (ja) 2017-08-14 2024-11-12 経皮カンナビジオールゲルを用いた変形性関節症の治療方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762545468P 2017-08-14 2017-08-14
US62/545,468 2017-08-14
US201862661733P 2018-04-24 2018-04-24
US62/661,733 2018-04-24
PCT/IB2018/056090 WO2019034985A1 (en) 2017-08-14 2018-08-13 METHODS OF TREATING ARTHROSIS USING CANNABIDIOL TRANSDERMAL GEL

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023087510A Division JP7590803B2 (ja) 2017-08-14 2023-05-29 経皮カンナビジオールゲルを用いた変形性関節症の治療方法

Publications (2)

Publication Number Publication Date
JP2020530857A JP2020530857A (ja) 2020-10-29
JP2020530857A5 true JP2020530857A5 (enExample) 2021-09-30

Family

ID=65362584

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020509441A Pending JP2020530857A (ja) 2017-08-14 2018-08-13 経皮カンナビジオールゲルを用いた変形性関節症の治療方法
JP2023087510A Active JP7590803B2 (ja) 2017-08-14 2023-05-29 経皮カンナビジオールゲルを用いた変形性関節症の治療方法
JP2024197147A Pending JP2025024068A (ja) 2017-08-14 2024-11-12 経皮カンナビジオールゲルを用いた変形性関節症の治療方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023087510A Active JP7590803B2 (ja) 2017-08-14 2023-05-29 経皮カンナビジオールゲルを用いた変形性関節症の治療方法
JP2024197147A Pending JP2025024068A (ja) 2017-08-14 2024-11-12 経皮カンナビジオールゲルを用いた変形性関節症の治療方法

Country Status (11)

Country Link
US (4) US20200170963A1 (enExample)
EP (1) EP3668500A4 (enExample)
JP (3) JP2020530857A (enExample)
KR (1) KR20200054171A (enExample)
AU (2) AU2018318425A1 (enExample)
BR (1) BR112020003025A2 (enExample)
CA (1) CA3072849A1 (enExample)
IL (2) IL301622A (enExample)
JO (1) JOP20200031A1 (enExample)
MX (1) MX2020001768A (enExample)
WO (1) WO2019034985A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3967301B1 (en) 2017-09-28 2024-06-19 Zynerba Pharmaceuticals, Inc. Treatment of irritability in autism spectrum disorder with cannabidiol
BR112021011279A2 (pt) 2018-12-14 2021-08-31 Zynerba Pharmaceuticals, Inc. Tratamento da síndrome de deleção 22q11.2 com canabidiol
CN114650809A (zh) 2019-10-03 2022-06-21 斯塔顿治疗公司 屈大麻酚的透皮递送
US12409131B2 (en) 2019-10-03 2025-09-09 Pike Therapeutics Usa, Inc. Transdermal delivery of dronabinol
US12016829B2 (en) 2019-10-11 2024-06-25 Pike Therapeutics Inc. Pharmaceutical composition and method for treating seizure disorders
JP7670700B2 (ja) 2019-10-11 2025-04-30 パイク セラピューティクス インコーポレイテッド 発作性障害の治療用のカンナビジオール（ｃｂｄ）を含む経皮医薬組成物
CA3156239A1 (en) * 2019-10-13 2021-04-22 Figene, Llc Cannabidiol adjuvant therapy for treatment of disc degenerative disease
US12268699B2 (en) 2019-10-14 2025-04-08 Pike Therapeutics Inc. Transdermal delivery of tetrahydrocannabinol
US12121617B2 (en) 2019-10-14 2024-10-22 Pike Therapeutics Inc. Transdermal delivery of cannabidiol
WO2021074790A1 (en) 2019-10-14 2021-04-22 Pike Therapeutics, Inc., 1219014 B.C. Ltd. Transdermal delivery of cannabidiol
CN115812000A (zh) * 2020-06-29 2023-03-17 Zyne制药公司 大麻二酚对脆性x综合征的治疗
AU2022257344A1 (en) * 2021-04-12 2023-10-26 Pike Therapeutics Inc. Transdermal delivery of cannabidiol
EP4098254A1 (en) * 2021-06-04 2022-12-07 Assistance Publique, Hopitaux De Paris Cannabidiol for use in the treatment of pain resulting from an indoleamine 2,3-dioxygenase-1 (ido1) related disease
WO2024085581A1 (ko) * 2022-10-17 2024-04-25 (주)인벤티지랩 염증성 질환의 치료 또는 예방을 위한 서방형 주사용 조성물 및 이의 제조 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9807639D0 (en) * 1998-04-14 1998-06-10 Kennedy Rheumatology Inst Anti-inflammatory agents
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
GB2414933B (en) * 2004-06-08 2009-07-15 Gw Pharma Ltd Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
JP5240925B2 (ja) * 2005-05-25 2013-07-17 カロシン ファーマ， インコーポレイテッド 変形性関節症を処置するための方法および組成物
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
EP3056217B1 (en) * 2008-12-22 2021-06-30 The University of Melbourne Osteoarthritis treatment
MX2011011514A (es) * 2009-04-28 2011-11-18 Alltranz Inc Formulaciones de canabidiol y metodos para utilizarlas.
AU2009345154A1 (en) * 2009-04-29 2011-12-22 University Of Kentucky Research Foundation Cannabinoid-containing compositions and methods for their use
WO2011026144A1 (en) * 2009-08-31 2011-03-03 Alltranz Inc. Use of cannabidiol prodrugs in topical and transdermal administration with microneedles
WO2014000031A1 (en) * 2012-06-26 2014-01-03 Rusty Property Holdings Pty Ltd Isolation of stem cells from adipose tissue by ultrasonic cavitation, and methods of use
AU2015289389A1 (en) * 2014-07-18 2017-09-14 Medipath, Inc. Compositions and methods for physiological delivery using Cannabidiol

Similar Documents

Publication Publication Date Title
JP2020530857A5 (enExample)
JP2023109969A5 (enExample)
CN101417060B (zh) 一种治疗外伤、跌打、斑秃及烧烫伤的药膏
RU2012148710A (ru) Органическое соединение для применения при лечении рака печени
JOP20200031A1 (ar) طرق لعلاج الالتهاب العظمي المفصلي باستخدام هلام من كانابيديول عبر الأدمة
RU2014150942A (ru) Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона
RU2015103107A (ru) Комбинированная композиция
CN104257970B (zh) 一种外用跌打药膏
JP2016505050A5 (enExample)
JP2019529569A5 (enExample)
CN103432551B (zh) 一种治疗肩周炎、网球肘、莫名骨痛的外敷药物
RU2018130097A (ru) Лечение экземы кистей
CN102988277A (zh) 一种治疗皮肤疣、甲真菌病和胼胝等皮肤病的油膏
CN103638155B (zh) 治疗足跟痛的外用中药制剂
CN105267577B (zh) 一种治疗流行性腮腺炎的贴膏及其制备方法
CN103142923B (zh) 一种治疗冠心病的复方蒙药制剂
BR112017022478A2 (pt) composição farmacêutica de liberação sustentada que contém rivastigmina
CN101837068B (zh) 椒目仁油喷雾剂的制备工艺和应用
CN104800763B (zh) 一种活血化瘀的载药针灸针
CN105596504A (zh) 一种外敷双柏散及其制备方法
CN102772472A (zh) 一种治疗寻常疣的酊剂药物
CN104721254A (zh) 一种愈肤生肌膏
CN104225030B (zh) 一种治疗手足癣汗臭脚的浸泡液及其制备方法
RU2539422C1 (ru) Способ лечения кариеса зубов
CN102512650A (zh) 一种治疗面神经麻痹的外用药物